SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maple MAGA who wrote (1312692)8/13/2021 10:42:45 PM
From: Broken_Clock2 Recommendations

Recommended By
FJB
Mick Mørmøny

  Read Replies (1) of 1582943
 
geertvandenbossche.org

In parallel with universal vaccination, more infectious strains have rapidly expanded in prevalence. According to molecular epidemiologists, Sars-CoV-2 is now also rapidly evolving towards resistance to S-specific Sars-CoV-2 Abs (9, 10). They have ascribed this to S-directed immune pressure that is now rapidly building up in the population. There can be no doubt that resistance to vaccinal Abs will be the endpoint of any mass vaccination program that uses modern vaccines during a pandemic of an acute self-limiting viral disease caused by a highly mutable virus. Contrary to live vaccines, vaccines produced by modern vaccine technologies fail to induce sterilizing immunity ( *3). Failure to do so inevitably leads to selection and adaptation of more and more infectious variants and eventually forces the virus into resistance to neutralizing Abs in order to survive.



As abundantly reported in the literature and social media, vaccinated subjects do not only spread Sars-CoV-2 variants ( *4) but are now also increasingly developing symptomatic infections ( *5).

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext